Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) traded down 10.1% during trading on Friday after Canaccord Genuity Group lowered their price target on the stock from $40.00 to $34.00. Canaccord Genuity Group currently has a buy rating on the stock. Trupanion traded as low as $21.32 and last traded at $21.38. 502,239 shares traded hands during mid-day trading, a decline of 24% from the average session volume of 659,466 shares. The stock had previously closed at $23.78.
Several other brokerages have also commented on TRUP. Evercore ISI decreased their price objective on shares of Trupanion from $35.00 to $31.00 and set an “outperform” rating on the stock in a report on Tuesday, February 20th. Piper Sandler cut their target price on Trupanion from $28.00 to $22.00 and set a “neutral” rating on the stock in a research report on Friday. Finally, Stifel Nicolaus raised their price target on Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a research report on Friday, February 16th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $32.33.
Get Our Latest Stock Report on TRUP
Institutional Investors Weigh In On Trupanion
Trupanion Trading Down 16.5 %
The company’s fifty day moving average is $25.67 and its two-hundred day moving average is $26.77. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The stock has a market cap of $833.60 million, a price-to-earnings ratio of -18.38 and a beta of 1.76.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.02. The business had revenue of $306.12 million for the quarter, compared to analyst estimates of $300.51 million. Trupanion had a negative net margin of 4.03% and a negative return on equity of 15.19%. The company’s revenue was up 19.4% on a year-over-year basis. During the same period last year, the business earned ($0.60) EPS. On average, research analysts predict that Trupanion, Inc. will post -0.43 EPS for the current fiscal year.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- 3 Healthcare Dividend Stocks to Buy
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is a Dividend King?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.